An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial. Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, et al. Circulation 2023 Nov 23. doi: 10.1161/CIRCULATIONAHA.123.066720.

Read + Share

Amedeo Smart

Independent Medical Education

Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, et al. An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial. Circulation 2023 Nov 23. doi: 10.1161/CIRCULATIONAHA.123.066720.
PMID: 37994553